Alterola Biotech, Inc. (ABTI) Stock

About Alterola Biotech, Inc.

Alterola Biotech, Inc. is a pharmaceutical company dedicated to the research and development of cannabinoid and cannabinoid-like molecules. The firm primarily focuses on pioneering regulated pharmaceutical products for human and animal health, as well as regulated food items. Key activities also include the production of active pharmaceutical ingredients (APIs) and food-grade components. Furthermore, the company emphasizes drug formulation and advanced delivery systems to improve bioavailability, solubility, and overall stability. It operates out of Birkenhead, United Kingdom.

Alterola Biotech, Inc. (ABTI) stock trades at $0.00 with a market capitalization of $291900. The stock is valued at a negative price-to-earnings (P/E) ratio of -0.11, reflecting a net loss over the last twelve months, price-to-book of 0.03, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.20, and currently trades 100.0% below its 52-week high.

On profitability, Alterola Biotech, Inc. generates a return on equity (ROE) of -20.00% (negative, reflecting a net loss), return on capital employed of -18.51%.

Official website: alterola-abti.com